MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24 Stock MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24
Add to a list
To use this feature you must be a member
Log inSign up

MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24 Share Price

Warrant

DE000ME66BM6

Market Closed - Börse Stuttgart 20:22:56 31/05/2024 BST
0.013 EUR -.--% Intraday chart for MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24
3 months-56.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/80/0.1/20.12.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes RE
GSK blood cancer drug nearly halves risk of death in late-stage trial RE
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer BU
Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma MT
More news

Quotes 5-day view

Date Price Change
31/05/24 0.013 -.--%
30/05/24 0.013 -.--%
29/05/24 0.013 -.--%
28/05/24 0.013 +8.33%
27/05/24 0.012 -7.69%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 08:22 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
Issuer Morgan Stanley
WKN ME66BM
ISINDE000ME66BM6
Date issued 02/01/2024
Strike 80 $
Maturity 20/12/2024 (201 Days)
Parity 10 : 1
Emission price 0.07 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.039 €
Lowest since issue 0.01 €
Delta0.05x
Omega 7.273
Premium96.54x
Gearing142.08x
Moneyness 0.5106
Difference Strike 38.88 $
Difference Strike %+48.59%
Spread 0.027 €
Spread %67.50%
Theoretical value 0.0265
Implied Volatility 49.70 %
Total Loss Probability 97.69 %
Intrinsic value 0.000000
Present value 0.0265
Break even 80.29 €
Theta-0x
Vega0x
Rho0x

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09 USD
Average target price
53.19 USD
Spread / Average Target
+29.46%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant